Litcius/Paper detail

Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients

Lang Wang, Wenbo He, Xiaomei Yu, Dalong Hu, Hong Jiang

2020World Journal of Clinical Cases50 citationsDOIOpen Access PDF

Abstract

BACKGROUND: The prognostic value of coagulation disorder in coronavirus disease 2019 (COVID-19) patients should be demonstrated. AIM: To investigate the abnormalities of coagulation parameters in the patients with COVID-19 and their prognostic values. METHODS: Consecutive patients admitted in the isolation ward of Renmin Hospital of Wuhan University from January 31 to February 5, 2020 with confirmed COVID-19 were included. The primary outcomes were death and survival as of March 11. Demographics, vital signs, comorbidities and laboratory tests were collected and compared between those who died and survivors. Logistic regression analysis for prognostic factors was performed. Kaplan-Meier analysis was used to compare the estimated survival rate between patients with prolonged prothrombin time and normal prothrombin time. RESULTS: < 0.001). CONCLUSION: Prothrombin time, concentration of fibrin degradation products, respiration rate and age were predictive factors for clinical outcomes of COVID-19 patients.

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Prothrombin time2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicinePartial thromboplastin timeEmergency medicineIntensive care medicineVirologyCoagulationDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and ThrombosisSepsis Diagnosis and Treatment
Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients | Litcius